Overall Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Versus Dipeptidyl-Peptidase 4 Inhibitors: Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT study)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Overall Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Versus Dipeptidyl-Peptidase 4 Inhibitors: Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT study) ; volume:14 ; number:9 ; day:6 ; month:7 ; year:2023 ; pages:1517-1535 ; date:9.2023
Diabetes therapy ; 14, Heft 9 (6.7.2023), 1517-1535, 9.2023
- Creator
-
Sugawara, Masahiro
Fukuda, Masahiro
Sakuma, Ichiro
Wakasa, Yutaka
Funayama, Hideaki
Kondo, Akira
Itabashi, Naoki
Maruyama, Yasuyuki
Kamiyama, Takashi
Utsunomiya, Yasunori
Yamauchi, Akira
Yoshii, Hidenori
Yamada, Hirokazu
Mochizuki, Koichi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13300-023-01438-w
- URN
-
urn:nbn:de:101:1-2023110108285548613089
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sugawara, Masahiro
- Fukuda, Masahiro
- Sakuma, Ichiro
- Wakasa, Yutaka
- Funayama, Hideaki
- Kondo, Akira
- Itabashi, Naoki
- Maruyama, Yasuyuki
- Kamiyama, Takashi
- Utsunomiya, Yasunori
- Yamauchi, Akira
- Yoshii, Hidenori
- Yamada, Hirokazu
- Mochizuki, Koichi
- SpringerLink (Online service)
Other Objects (12)
Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis
![Untersuchung von N-Dipeptidyl-O-(4-Nitrobenzoyl)-Hydroxylaminen [N-Dipeptidyl-O-Nitrobenzoyl-Hydroxylaminen] als enzymaktivierte Inhibitoren der Dipeptidyl-Peptidase IV](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Untersuchung von N-Dipeptidyl-O-(4-Nitrobenzoyl)-Hydroxylaminen [N-Dipeptidyl-O-Nitrobenzoyl-Hydroxylaminen] als enzymaktivierte Inhibitoren der Dipeptidyl-Peptidase IV
Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus
Dipeptidyl-Peptidase 4 Inhibitor-Induced Variants of Bullous Pemphigoid: A Case Series of Four Patients
Effect of Luseogliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, and Dipeptidyl-Peptidase 4 Inhibitors on the Quality-of-Life and Treatment Satisfaction of Patients With Type 2 Diabetes Mellitus: A Subanalysis of a Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT Study)
Dipeptidyl-peptidase IV inhibitor (DPP4i) confers increased odds of bullous pemphigoid even years after drug initiation
Dipeptidyl-Peptidase IV : Biochemie, Physiologie u. Pathobiochemie
Beiträge zur kinetischen Charakterisierung der Dipeptidyl-Peptidase IV
Combination of sodium-glucose cotransporter 2 inhibitor and dipeptidyl peptidase-4 inhibitor in type 2 diabetes: a systematic review with meta-analysis
Comparing sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset depression: a propensity score-matched study in Hong Kong
Angioedema associated with dipeptidyl peptidase-IV inhibitors
Wirkung des Dipeptidylpeptidase-4-Inhibitors Sitagliptin auf retinale Endothelzellen
Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis
Untersuchung von N-Dipeptidyl-O-(4-Nitrobenzoyl)-Hydroxylaminen [N-Dipeptidyl-O-Nitrobenzoyl-Hydroxylaminen] als enzymaktivierte Inhibitoren der Dipeptidyl-Peptidase IV
Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus
Dipeptidyl-Peptidase 4 Inhibitor-Induced Variants of Bullous Pemphigoid: A Case Series of Four Patients
Effect of Luseogliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, and Dipeptidyl-Peptidase 4 Inhibitors on the Quality-of-Life and Treatment Satisfaction of Patients With Type 2 Diabetes Mellitus: A Subanalysis of a Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT Study)
Dipeptidyl-peptidase IV inhibitor (DPP4i) confers increased odds of bullous pemphigoid even years after drug initiation
Dipeptidyl-Peptidase IV : Biochemie, Physiologie u. Pathobiochemie
Beiträge zur kinetischen Charakterisierung der Dipeptidyl-Peptidase IV
Combination of sodium-glucose cotransporter 2 inhibitor and dipeptidyl peptidase-4 inhibitor in type 2 diabetes: a systematic review with meta-analysis
Comparing sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset depression: a propensity score-matched study in Hong Kong
Angioedema associated with dipeptidyl peptidase-IV inhibitors
Wirkung des Dipeptidylpeptidase-4-Inhibitors Sitagliptin auf retinale Endothelzellen
Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis
Untersuchung von N-Dipeptidyl-O-(4-Nitrobenzoyl)-Hydroxylaminen [N-Dipeptidyl-O-Nitrobenzoyl-Hydroxylaminen] als enzymaktivierte Inhibitoren der Dipeptidyl-Peptidase IV
Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus
Dipeptidyl-Peptidase 4 Inhibitor-Induced Variants of Bullous Pemphigoid: A Case Series of Four Patients
Effect of Luseogliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, and Dipeptidyl-Peptidase 4 Inhibitors on the Quality-of-Life and Treatment Satisfaction of Patients With Type 2 Diabetes Mellitus: A Subanalysis of a Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT Study)
Dipeptidyl-peptidase IV inhibitor (DPP4i) confers increased odds of bullous pemphigoid even years after drug initiation
Dipeptidyl-Peptidase IV : Biochemie, Physiologie u. Pathobiochemie
Beiträge zur kinetischen Charakterisierung der Dipeptidyl-Peptidase IV
Combination of sodium-glucose cotransporter 2 inhibitor and dipeptidyl peptidase-4 inhibitor in type 2 diabetes: a systematic review with meta-analysis
Comparing sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset depression: a propensity score-matched study in Hong Kong
Angioedema associated with dipeptidyl peptidase-IV inhibitors